Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catalent, Inc. Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
Catalent, Inc. Reports Fourth Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
News headline image
Fear & Greed Index Moves To 'Fear' Zone As Dow Dips Over 1,000 Points Following Powell's Speech ↗
The CNN Money Fear and Greed index moved to the "fear" zone after the Dow Jones dipped more than 1,000 points on Friday following Powell’s comments. Fed Chair Jerome Powell, at the Jackson Hole... 
Via Benzinga
News headline image
Dow, Nasdaq Futures Lower Following Friday's Sell-Off; US Dollar Surges To 20-Year High ↗
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 1,000 points in the previous session following speech from Federal Reserve Chairman... 
Via Benzinga
News headline image
Earnings Scheduled For August 29, 2022 ↗
Companies Reporting Before The Bell • NAPCO Security (NASDAQ:NSSC) is expected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says ↗
 
Via Benzinga
News headline image
Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report ↗
 
Via Benzinga
News headline image
Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook ↗
 
Via Benzinga
News headline image
Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday ↗
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Bitcoin Tumbles Below This Major Level Following Powell's Remarks; Here Are The Top Crypto Movers For Monday ↗
Bitcoin (CRYPTO: BTC), the world’s most valued cryptocurrency, recorded a massive sell-off, with price for the cryptocurrency falling below the $20,000 level this morning following comments from US... 
Via Benzinga
News headline image
Catalent's Earnings: A Preview ↗
Catalent (NYSE:CTLT) is set to give its latest quarterly earnings report on Monday, 2022-08-29. Here's what investors need to know before the announcement. Analysts estimate that Catalent will report... 
Via Benzinga
News headline image
Catalent to Acquire Metrics Contract Services for $475 Million to Expand High-Potent Capabilities and Oral Development and Manufacturing Capacity
From Catalent, Inc.
Via Business Wire
News headline image
Recap: Catalent Q3 Earnings ↗
Catalent (NYSE:CTLT) reported its Q3 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Why Erytech Pharma Are Shares Moving Higher Today ↗
 
Via Benzinga
News headline image
Catalent, Inc. Announces Fourth Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
News headline image
Is Novavax Stock A Buy After Omicron Results Impress Two FDA Experts? ↗
The FDA is reviewing additional manufacturing data before making a decision. 
Via Investor's Business Daily
News headline image
Catalent Announces New Operating Structure
From Catalent, Inc
Via Business Wire
News headline image
Catalent, Inc. to Present at June Investor Conferences
From Catalent, Inc.
Via Business Wire
News headline image
Quant Ratings Updated on 75 Stocks ↗
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace
News headline image
Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know ↗
Morgan Stanley has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $145.00 to $132.00. Shares of Catalent are trading up 1.11% over the last 24 hours,... 
Via Benzinga
News headline image
80 Biggest Movers From Yesterday ↗
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... 
Via Benzinga
News headline image
Stocks Stage Midday Rally as Bond Yields Cool ↗
Stocks are rallying this afternoon, as investors prepare for the Federal Reserve's interest rate decision, which is due out tomorrow. 
Via Talk Markets
News headline image
41 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers SoundHound AI, Inc. (NASDAQ: SOUN) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday. Sonoma... 
Via Benzinga
News headline image
Catalent, Inc. Reports Third Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
News headline image
How To Attend Catalent Q3 2022 Earnings Conference Call ↗
Catalent (NYSE:CTLT) will host a conference call at 08:15 AM ET on May 3, 2022, to discuss Q3 2022 earnings results. How to Attend Catalent (CTLT) Conference Call Follow this link to access the live... 
Via Benzinga
News headline image
Catalent, Inc. Announces Third Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
News headline image
24 Biggest Movers From Yesterday ↗
Gainers Vertical Aerospace Ltd. (NYSE: EVTL) Shares hiked 30.93% to close at $9.82 on Tuesday after Deutsche Bank initiated coverage of the stock. Peabody Energy Corporation (... 
Via Benzinga
News headline image
Markets Fall As Investors Weigh March CPI Report ↗
U.S. indices sold off to close Tuesday’s session following earlier strength. Investors reacted to the March CPI report and continue to assess Fed rate hike concerns. While... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
From Catalent, Inc.
Via Business Wire
News headline image
Novo Nordisk Doubles 2025 Sales Target On Strong Wegovy Demand ↗
Novo Nordisk A/S (NYSE: NVO) has more than doubled its target for sales of obesity drugs by 2025 after overwhelming demand for its new Wegovy drug. Novo Nordisk aims to... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.